Editorial: New therapeutic approaches for SARS-CoV-2/COVID-19

Abstract

After three years and a half since the pandemic due to the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) causing Coronavirus Disease 2019 (COVID-19) started (1), there has been an enormous impact in terms of morbidity and mortality due to this emerging pathogen (2). Up to August 9, 2023, there have been more than 769.37 million cases, with 6.95 million deaths, as reported to the World Health Organization (WHO) (Figure 1). Multiple advances during this time have been vital in controlling and ceasing the pandemic condition and the recent declaration to lift the international public health emergency in May 2023. One of them is undoubtedly related to the impact of preventing multiple outcomes (including deaths) of efficacious, safe and effective globally deployed vaccines against SARS-CoV-2 (3, 4). As of August 9, 2023, 13,492 million vaccine doses have been administered (Figure 1)...